Mild and moderate hepatic impairment
Showing 1 - 25 of >10,000
Hepatic Impairment Trial in Hialeah (Avacopan)
Completed
- Hepatic Impairment
-
Hialeah, FloridaClinical Pharmacology of Miami, Inc.
Aug 15, 2023
Esophageal Cancer, Advanced Solid Tumor Trial in Chendu (Larotinib)
Not yet recruiting
- Esophageal Cancer
- Advanced Solid Tumor
-
Chendu, Sichuan, ChinaWest China Hospital of Sichuan University
May 4, 2022
Non-alcoholic Steatohepatitis, Hepatic Impairment, Cirrhosis Trial in Orlando, San Antonio, Kistarcsa (TVB-2640 - 50 mg)
Not yet recruiting
- Non-alcoholic Steatohepatitis
- +2 more
- TVB-2640 - 50 mg
-
Orlando, Florida
- +2 more
Apr 17, 2023
Hepatic Function Abnormal Trial (Fexinidazole (HOE239))
Not yet recruiting
- Hepatic Function Abnormal
- Fexinidazole (HOE239)
- (no location specified)
Jan 10, 2023
Diabetes Trial (Retagliptin Phosphate Tablet)
Not yet recruiting
- Diabetes
- Retagliptin Phosphate Tablet
- (no location specified)
Sep 7, 2023
Hepatic Impairment Trial in Changchun (SHR0302)
Completed
- Hepatic Impairment
-
Changchun, Jilin, ChinaThe First Affiliated Hospital of Jilin University
Oct 13, 2021
Patients With Mild or Moderate Hepatic Impairment Trial in Tokyo (TS-142 5 mg)
Recruiting
- Patients With Mild or Moderate Hepatic Impairment
- TS-142 5 mg
-
Tokyo, JapanTaisho Pharmaceutical Co., Ltd selected site
Dec 27, 2022
Hepatic Function Abnormal Trial in Germany, United States (Venglustat (GZ402671))
Recruiting
- Hepatic Function Abnormal
- Venglustat (GZ402671)
-
Miami, Florida
- +3 more
Jan 30, 2023
Hepatic Impairment and Myelosuppression in Breast Cancer
Not yet recruiting
- Breast Cancer
- (no location specified)
Jun 11, 2023
Prevention of Thromboembolic Events, Atrial Fibrillation, Acute Myocardial Infarction Trial in Kiel (Asundexian (BAY2433334))
Recruiting
- Prevention of Thromboembolic Events
- +4 more
- Asundexian (BAY2433334)
-
Kiel, Schleswig-Holstein, GermanyCRS-Kiel
Jan 17, 2023